Institutional investors hold a majority ownership of TMO through the 93.56% of the outstanding shares that they control. This interest is also higher than at almost any other company in the Medical Specialties industry. Last, during the quarter ended December 2013, these large investors purchased a net $4.9 million shares.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
AMUNDI SMITH BREEDEN LLC Bought 82.4 Thousand shares of Thermo Fisher Scientific ...